At a glance
- Originator Bristol-Myers Squibb
- Class Antipsychotics; Benzamides
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 13 Mar 2001 Discontinued-Preclinical for Schizophrenia in USA (Unknown route)
- 05 Feb 1997 No-Development-Reported for Schizophrenia in USA (Unknown route)